Acadia Pharma (ACAD) Tops Q3 EPS by 17c
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $28.24 --0%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
VISL, GNLN, USDP, More
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
VISL, GNLN, USDP, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q3 EPS of ($0.09), $0.17 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $131.6 million versus the consensus estimate of $127.75 million.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
